HuGE Literature Finder
Records
1
-
30
| Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane. The journal of gene medicine 2022 Jun e3434. Sun Zhiwei, Yang Xin, Du Feng, Shi Youwu, Sun Jing, Jia Jun, Liu Chuanling, Xiao Yanjie, Yu Jing, Zhang Xiaodong, Yang Yi |
| Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy. The journal of gene medicine 2022 10 25 (1): e3460. Sharma Parul, Singh Navneet, Sharma Siddhar |
| Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines. Cancers 2021 4 13 (6): . Amuzu Setor, Carmona Euridice, Mes-Masson Anne-Marie, Greenwood Celia M T, Tonin Patricia N, Ragoussis Jiann |
| Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinoma. Journal of pharmacological sciences 2021 12 148 (1): 6-13. Okubo Hironao, Ando Hitoshi, Ishizuka Kei, Morishige Jun-Ichi, Ikejima Kenichi, Shiina Shuichiro, Nagahara Akihi |
| Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma. Frontiers in pharmacology 2021 3 12 641075. Sun Fengjun, Chen Zhuo, Yao Pu, Weng Bangbi, Liu Zhirui, Cheng L |
| Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma. Future oncology (London, England) 2021 3 17 (18): 2351-2363. Yang Ying, Jia Jun, Sun Zhiwei, Liu Chuanling, Li Ziwei, Xiao Yanjie, Yu Jing, Du Feng, Shi Youwu, Sun Jing, Shui Jing, Zhang Xiaodo |
| Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma. Surgical oncology 2020 Sep 35 388-398. Puerta-García E, Urbano-Pérez D, Carrasco-Campos M I, Pérez-Ramírez C, Segura-Pérez A, Calleja-Hernández , Cañadas-Garre |
| Different response rates to chemotherapy between Japanese and German esophageal squamous cell carcinoma: patients may be influenced by ERCC1 or ABCB1. Future oncology (London, England) 2020 7 16 (27): 2075-2087. Narumiya Kosuke, Bollschweiler Elfriede, Hölscher Arnulf H, Yamamoto Masakazu, Drebber Uta, Alakus Hakan, Metzger Ralf, Warnecke-Eberz U |
| Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population. Medical science monitor : international medical journal of experimental and clinical research 2019 Apr 25 2959-2965. Zhang Shudong, Wang Binshuai, Zhang Fan, Ye Jianfei, Ge Liyuan, Ma Lul |
| Association of a genetic variant in ATP-binding cassette sub-family B member 1 gene with poor prognosis in patients with squamous cell carcinoma of the esophagus. IUBMB life 2019 Mar . Rastgar-Moghadam Azam, Mehramiz Mehrane, Shahidsales Soodabeh, Entezari Malihe, Hassanian Seyed Mahdi, Talebian Sahar, Nourbakhsh Mahnaz, Ferns Gordon A, Avan Am |
| Development of high?resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinoma. Oncology reports 2019 6 42 (2): 763-774. Vaclavikova Radka, Klajic Jovana, Brynychova Veronika, Elsnerova Katerina, Alnaes Grethe I G, Tost Jörg, Kristensen Vessela N, Rob Lukas, Kodet Roman, Skapa Petr, Mrhalova Marcela, Soucek Pav |
| Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma. Pharmacogenomics 2019 12 20 (18): 1283-1290. Goey Andrew Kl, With Mirjam de, Agema Bram C, Hoop Esther Oomen-De, Singh Rajbir K, van der Veldt Astrid Am, Mathijssen Ron Hj, van Schaik Ron Hn, Bins Sand |
| Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma. Oncotarget 2018 Mar 9 (18): 14109-14123. Zhang Yuanyuan, Mai Haixing, Guo Gang, Bi Guofang, Hao Guangtao, Li Yuanyuan, Wang Xiaofang, Cheng Longmei, Wang Jing, Dong Ruihua, Liu Zeyuan, Chen Lijun, Qu Hengy |
| Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma. Medical oncology (Northwood, London, England) 2018 Mar 35 (4): 51. Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
| Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma. Oncotarget 2018 Mar 9 (24): 17160-17170. Yamamoto Yoshiaki, Tsunedomi Ryouichi, Fujita Yusuke, Otori Toru, Ohba Mitsuyoshi, Kawai Yoshihisa, Hirata Hiroshi, Matsumoto Hiroaki, Haginaka Jun, Suzuki Shigeo, Dahiya Rajvir, Hamamoto Yoshihiko, Matsuyama Kenji, Hazama Shoichi, Nagano Hiroaki, Matsuyama Hideya |
| Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma. International journal of cancer 2018 8 143 (12): 3181-3193. Reustle Anna, Fisel Pascale, Renner Olga, Büttner Florian, Winter Stefan, Rausch Steffen, Kruck Stephan, Nies Anne T, Hennenlotter Jörg, Scharpf Marcus, Fend Falko, Stenzl Arnulf, Bedke Jens, Schwab Matthias, Schaeffeler El |
| ABCB1 3435TT and ABCG2 421CC genotypes were significantly associated with longer progression-free survival in Chinese breast cancer patients. Oncotarget 2017 Dec 8 (67): 111041-111052. Li Wanjun, Zhang Dan, Du Fen, Xing Xuemei, Wu Ying, Xiao Dong, Liang Ming, Fan Zhigang, Zhao Peng, Liu Tao, Li Guoy |
| Genetic biomarkers for hepatocellular cancer risk in a caucasian population. World journal of gastroenterology 2017 Sep 23 (36): 6674-6684. De Mattia Elena, Cecchin Erika, Polesel Jerry, Bignucolo Alessia, Roncato Rossana, Lupo Francesco, Crovatto Marina, Buonadonna Angela, Tiribelli Claudio, Toffoli Giusep |
| Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer chemotherapy and pharmacology 2017 Jul . Mbatchi Litaty C, Gassiot Matthieu, Pourquier Philippe, Goberna Alejando, Mahammedi Hakim, Mourey Loic, Joly Florence, Lumbroso Serge, Evrard Alexandre, Houede Nadi |
| Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study. Cancer chemotherapy and pharmacology 2017 Mar . Tandia Mahamadou, Mhiri Asma, Paule Bernard, Saffroy Raphaël, Cailliez Valérie, Noé Gaëlle, Farinotti Robert, Bonhomme-Faivre Lauren |
| Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients. Biological & pharmaceutical bulletin 2017 40 (4): 458-464. Watanabe Aimi, Yamamoto Kazuhiro, Ioroi Takeshi, Hirata Sachi, Harada Kenichi, Miyake Hideaki, Fujisawa Masato, Nakagawa Tsutomu, Yano Ikuko, Hirai Mido |
| Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma. European urology focus 2016 Dec 2 (6): 633-639. de Velasco Guillermo, Gray Kathryn P, Hamieh Lana, Urun Yuksel, Carol Hallie A, Fay Andre P, Signoretti Sabina, Kwiatkowski David J, McDermott David F, Freedman Matthew, Pomerantz Mark M, Choueiri Toni |
| Association of Single-Nucleotide Polymorhism C3435T in the ABCB1 Gene with Opioid Sensitivity in Treatment of Postoperative Pain. Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 2016 Nov 37 (2-3): 73-80. Dzambazovska-Trajkovska Vanja, Nojkov Jordan, Kartalov Andrijan, Kuzmanovska Biljana, Spiroska Tatjana, Seljmani Redzep, Trajkovski Gjorgji, Matevska-Geshkovska Nadica, Dimovski Aleksand |
| Association of axitinib plasma exposure and genetic polymorphisms of ABC transporters with axitinib-induced toxicities in patients with renal cell carcinoma. Cancer chemotherapy and pharmacology 2016 Sep . Kato Hiroshi, Sassa Naoto, Miyazaki Masayuki, Takeuchi Mio, Asai Miho, Iwai Akane, Noda Yukihiro, Gotoh Momokazu, Yamada Kiyofu |
| BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing regimen. Cancer chemotherapy and pharmacology 2016 Aug . Chae Jung-Woo, Teo Yi Ling, Ho Han Kiat, Lee Jaeyeon, Back Hyun-Moon, Yun Hwi-Yeol, Karlsson Mats O, Kwon Kwang-Il, Chan Alexand |
| Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib. Anti-cancer drugs 2016 Aug . Numakura Kazuyuki, Tsuchiya Norihiko, Kagaya Hideaki, Takahashi Makoto, Tsuruta Hiroshi, Inoue Takamitsu, Narita Shintaro, Huang Mingguo, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
| Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer. Cancer chemotherapy and pharmacology 2016 May . de Wit D, Schneider T C, Moes D J A R, Roozen C F M, den Hartigh J, Gelderblom H, Guchelaar H J, van der Hoeven J J, Links T P, Kapiteijn E, van Erp N |
| SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma. Pharmacogenomics 2016 Mar . Duran Ignacio, Hagen Carlos, Arranz José Ángel, Apellaniz-Ruiz María, Pérez-Valderrama Begoña, Sala Nuria, Lainez Nuria, García-Del Muro Xavier, Noguerón Esther, Climent Miguel Ángel, Maroto Pablo, Font Albert, García-Donas Jesús, Gallardo Enrique, López-Criado Pilar, González Del Alba Aránzazu, Sáez María Isabel, Vázquez Sergio, Luque Raquel, Rodríguez-Antona Cristi |
| The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma. Scientific reports 2016 6 20089. Qin Chao, Cao Qiang, Li Pu, Wang Shangqian, Wang Jian, Wang Meilin, Chu Haiyan, Zhou Liqun, Li Xuesong, Ye Dingwei, Zhang Hailiang, Huang Yiran, Dong Baijun, Sun Xiaofeng, Zou Qing, Cai Hongzhou, Sun Lijiang, Zhu Jian, Liu Fade, Ji Junbiao, Cui Li, Wang Xiaoxiang, Zhou Hai, Zhao Hu, Wu Bin, Chen Jianchun, Jiang Minjun, Zhang Zhengdong, Shao Pengfei, Ju Xiaobing, Yin Changj |
| Impact of ABCB1 and CYP2D6 polymorphisms on tamoxifen treatment outcomes and adverse events in breast cancer patients. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 22 (5): 1217-1226. Argalacsova Sona, Slanar Ondrej, Bakhouche Hana, Pertuzelka Lub |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: